Recent Publications

2015 Publications

  1. Reynolds J, Preston GA, Pressler BM, Hewins P, Brown M, Roth A, Alderman E, Bunch D, Jennette JC, Cook HT, Falk RJ, Pusey CD. Autoimmunity to the alpha 3 chain of type IV collagen in glomerulonephritis is triggered by 'autoantigen complementarity'. J Autoimmun. 2015;59:8-18. Epub 2015/04/07. doi: 10.1016/j.jaut.2015.01.003. PubMed PMID: 25841937; PMCID: PMC4459745. (Read Abstract)
  2. Pendergraft WF, 3rd, Falk RJ. Understanding the role of rituximab in ANCA GN: regressing toward the mean. J Am Soc Nephrol. 2015;26(4):771-4. Epub 2014/11/09. doi: 10.1681/asn.2014100997. PubMed PMID: 25381425; PMCID: PMC4378114. (Read Text)
  3. McInnis EA, Badhwar AK, Muthigi A, Lardinois OM, Allred SC, Yang J, Free ME, Jennette JC, Preston GA, Falk RJ, Ciavatta DJ. Dysregulation of autoantigen genes in ANCA-associated vasculitis involves alternative transcripts and new protein synthesis. J Am Soc Nephrol. 2015;26(2):390-9. Epub 2014/07/26. doi: 10.1681/asn.2013101092. PubMed PMID: 25060059; PMCID: PMC4310652. (Read Abstract)
  4. McGregor JG, Negrete-Lopez R, Poulton CJ, Kidd JM, Katsanos SL, Goetz L, Hu Y, Nachman PH, Falk RJ, Hogan SL. Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function. Nephrol Dial Transplant. 2015;30 Suppl 1:i171-81. Epub 2015/03/26. doi: 10.1093/ndt/gfv045. PubMed PMID: 25805747. (Read Abstract)
  5. McGregor JG, Hogan SL, Kotzen ES, Poulton CJ, Hu Y, Negrete-Lopez R, Kidd JM, Katsanos SL, Bunch DO, Nachman PH, Falk RJ. Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant. 2015;30 Suppl 1:i123-31. Epub 2015/03/26. doi: 10.1093/ndt/gfv076. PubMed PMID: 25805743; PMCID: PMC4447867. (Read Abstract)
  6. Jennette JC, Falk RJ. ANCAs are also antimonocyte cytoplasmic autoantibodies. Clin J Am Soc Nephrol. 2015;10(1):4-6. Epub 2014/12/18. doi: 10.2215/cjn.11501114. PubMed PMID: 25516916; PMCID: PMC4284421. (Read Text)
  7. Jain K, Gupta A, Singh HK, Nickeleit V, Kshirsagar AV. Bile cast nephropathy. Kidney Int. 2015;87(2):484. Epub 2015/01/31. doi: 10.1038/ki.2014.233. PubMed PMID: 25635725. (Read Text)
  8. Grubbs V, Vittinghoff E, Beck JD, Kshirsagar AV, Wang W, Griswold ME, Powe NR, Correa A, Young B. The Association Between Periodontal Disease and Kidney Function Decline in African Americans: The Jackson Heart Study. J Periodontol. 2015:1-11. Epub 2015/06/26. doi: 10.1902/jop.2015.150195. PubMed PMID: 26110451. (Read Abstract)
  9. Gibson KL, Glenn D, Ferris ME. Back to the future: therapies for idiopathic nephrotic syndrome. Blood Purif. 2015;39(1-3):105-9. Epub 2015/02/11. doi: 10.1159/000368951. PubMed PMID: 25659288. (Read Abstract)
  10. Folsom AR, Tang W, Roetker NS, Kshirsagar AV, Derebail VK, Lutsey PL, Naik R, Pankow JS, Grove ML, Basu S, Key NS, Cushman M. Prospective study of sickle cell trait and venous thromboembolism incidence. J Thromb Haemost. 2015;13(1):2-9. Epub 2014/11/14. doi: 10.1111/jth.12787. PubMed PMID: 25393788; PMCID: PMC4294976. (Read Abstract)
  11. Flythe JE, Kshirsagar AV, Falk RJ, Brunelli SM. Associations of Posthemodialysis Weights above and below Target Weight with All-Cause and Cardiovascular Mortality. Clin J Am Soc Nephrol. 2015;10(5):808-16. Epub 2015/04/12. doi: 10.2215/cjn.10201014. PubMed PMID: 25862779; PMCID: PMC4422248. (Read Abstract)
  12. Ferris ME, Ferris MT, Okumura MJ, Cohen SE, Hooper SR. Health care transition preparation in youth with chronic conditions: working towards translational evidence with a patient perspective. J Pediatr Rehabil Med. 2015;8(1):31-7. Epub 2015/03/05. doi: 10.3233/prm-150316. PubMed PMID: 25737346. (Read Abstract)
  13. Ferris ME, Cuttance JR, Javalkar K, Cohen SE, Phillips A, Bickford K, Gibson K, Ferris MT, True K. Self-management and transition among adolescents/young adults with chronic or end-stage kidney disease. Blood Purif. 2015;39(1-3):99-104. Epub 2015/02/11. doi: 10.1159/000368978. PubMed PMID: 25662749. (Read Abstract)
  14. Chang EH, Gasim AH, Kerber ML, Patel JB, Glaubiger SA, Falk RJ, Jennette JC, Otey CA. Palladin is upregulated in kidney disease and contributes to epithelial cell migration after injury. Sci Rep. 2015;5:7695. Epub 2015/01/13. doi: 10.1038/srep07695. PubMed PMID: 25573828. (Read Abstract)
  15. Cao Y, Liu K, Tian Z, Hogan SL, Yang J, Poulton CJ, Falk RJ, Li W. PTPN22 R620W polymorphism and ANCA disease risk in white populations: a metaanalysis. J Rheumatol. 2015;42(2):292-9. Epub 2014/12/03. doi: 10.3899/jrheum.131430. PubMed PMID: 25448792; PMCID: PMC4314360. (Read Abstract)
  16. Butler AM, Olshan AF, Kshirsagar AV, Edwards JK, Nielsen ME, Wheeler SB, Brookhart MA. Cancer Incidence Among US Medicare ESRD Patients Receiving Hemodialysis, 1996-2009. Am J Kidney Dis. 2015;65(5):763-72. Epub 2015/02/11. doi: 10.1053/j.ajkd.2014.12.013. PubMed PMID: 25662835. (Read Abstract)
  17. Bunch DO, Mendoza CE, Aybar LT, Kotzen ES, Colby KR, Hu Y, Hogan SL, Poulton CJ, Schmitz JL, Falk RJ, Nachman PH, Pendergraft WF, McGregor JG. Gleaning relapse risk from B cell phenotype: decreased CD5+ B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitis. Ann Rheum Dis. 2015. Epub 2015/05/03. doi: 10.1136/annrheumdis-2014-206756. PubMed PMID: 25934841. 
  18. Aybar LT, McGregor JG, Hogan SL, Hu Y, Mendoza CE, Brant EJ, Poulton CJ, Henderson CD, Falk RJ, Bunch DO. Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies. Clin Exp Immunol. 2015;180(2):178-88. Epub 2014/11/08. doi: 10.1111/cei.12483. PubMed PMID: 25376552; PMCID: PMC4408152. (Read Abstract)

2014 Publications

  1. Xiao H, Dairaghi DJ, Powers JP, Ertl LS, Baumgart T, Wang Y, Seitz LC, Penfold ME, Gan L, Hu P, Lu B, Gerard NP, Gerard C, Schall TJ, Jaen JC, Falk RJ, Jennette JC. C5a receptor (CD88) blockade protects against MPO-ANCA GN. J Am Soc Nephrol. 2014;25(2):225-31. Epub 2013/11/02. doi: 10.1681/asn.2013020143. PubMed PMID: 24179165; PMCID: PMC3904560. (Read Abstract)
  2. Selewski DT, Massengill SF, Troost JP, Wickman L, Messer KL, Herreshoff E, Bowers C, Ferris ME, Mahan JD, Greenbaum LA, MacHardy J, Kapur G, Chand DH, Goebel J, Barletta GM, Geary D, Kershaw DB, Pan CG, Gbadegesin R, Hidalgo G, Lane JC, Leiser JD, Song PX, Thissen D, Liu Y, Gross HE, DeWalt DA, Gipson DS. Gaining the Patient Reported Outcomes Measurement Information System (PROMIS) perspective in chronic kidney disease: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol. 2014;29(12):2347-56. Epub 2014/06/09. doi: 10.1007/s00467-014-2858-8. PubMed PMID: 24908324; PMCID: PMC4213233. (Read Abstract)
  3. Naik RP, Derebail VK, Grams ME, Franceschini N, Auer PL, Peloso GM, Young BA, Lettre G, Peralta CA, Katz R, Hyacinth HI, Quarells RC, Grove ML, Bick AG, Fontanillas P, Rich SS, Smith JD, Boerwinkle E, Rosamond WD, Ito K, Lanzkron S, Coresh J, Correa A, Sarto GE, Key NS, Jacobs DR, Kathiresan S, Bibbins-Domingo K, Kshirsagar AV, Wilson JG, Reiner AP. Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans. JAMA. 2014;312(20):2115-25. Epub 2014/11/14. doi: 10.1001/jama.2014.15063. PubMed PMID: 25393378; PMCID: PMC4356116. (Read Abstract)
  4. Lee T, Gasim A, Derebail VK, Chung Y, McGregor JG, Lionaki S, Poulton CJ, Hogan SL, Jennette JC, Falk RJ, Nachman PH. Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure. Clin J Am Soc Nephrol. 2014;9(5):905-13. Epub 2014/03/01. doi: 10.2215/cjn.08290813. PubMed PMID: 24578329; PMCID: PMC4011446. (Read Abstract)
  5. Lee T, Biddle AK, Lionaki S, Derebail VK, Barbour SJ, Tannous S, Hladunewich MA, Hu Y, Poulton CJ, Mahoney SL, Charles Jennette J, Hogan SL, Falk RJ, Cattran DC, Reich HN, Nachman PH. Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy. Kidney Int. 2014;85(6):1412-20. Epub 2013/12/18. doi: 10.1038/ki.2013.476. PubMed PMID: 24336031; PMCID: PMC4040154. (Read Abstract)
  6. Layton JB, Klemmer PJ, Christiansen CF, Bomback AS, Baron JA, Sandler RS, Kshirsagar AV. Sodium phosphate does not increase risk for acute kidney injury after routine colonoscopy, compared with polyethylene glycol. Clin Gastroenterol Hepatol. 2014;12(9):1514-21 e3. Epub 2014/02/04. doi: 10.1016/j.cgh.2014.01.034. PubMed PMID: 24486407. (Read Abstract)
  7. Joy MS, Roberts BV, Wang J, Hu Y, Hogan SL, Falk RJ. A pilot study of leukocyte expression patterns for drug metabolizing enzyme and transporter transcripts in autoimmune glomerulonephritis. Int J Clin Pharmacol Ther. 2014;52(4):303-13. Epub 2014/02/20. doi: 10.5414/cp201972. PubMed PMID: 24548980; PMCID: PMC4123858. (Read Abstract)
  8. Joy MS, Frye RF, Nolin TD, Roberts BV, La MK, Wang J, Brouwer KL, Dooley MA, Falk RJ. In vivo alterations in drug metabolism and transport pathways in patients with chronic kidney diseases. Pharmacotherapy. 2014;34(2):114-22. Epub 2013/09/17. doi: 10.1002/phar.1347. PubMed PMID: 24038489; PMCID: PMC3945423. (Read Abstract)
  9. Jennette JC, Falk RJ. B cell-mediated pathogenesis of ANCA-mediated vasculitis. Semin Immunopathol. 2014;36(3):327-38. Epub 2014/04/30. doi: 10.1007/s00281-014-0431-y. PubMed PMID: 24777746; PMCID: PMC4084547. (Read Abstract)
  10. Jennette JC, Falk RJ. Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol. 2014;10(8):463-73. Epub 2014/07/09. doi: 10.1038/nrrheum.2014.103. PubMed PMID: 25003769. (Read Abstract)
  11. Geetha D, Poulton CJ, Hu Y, Seo P, McGregor JA, Falk RJ, Hogan SL. Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans. Semin Arthritis Rheum. 2014;43(6):778-83. Epub 2014/01/07. doi: 10.1016/j.semarthrit.2013.11.011. PubMed PMID: 24387818; PMCID: PMC4086456. (Read Abstract)
  12. Freburger JK, Ellis AR, Kshirsagar AV, Wang L, Brookhart MA. Comparative short-term safety of bolus versus maintenance iron dosing in hemodialysis patients: a replication study. BMC Nephrol. 2014;15:154. Epub 2014/09/24. doi: 10.1186/1471-2369-15-154. PubMed PMID: 25245951; PMCID: PMC4182851. (Read Abstract)
  13. Derebail VK, Lacson EK, Jr., Kshirsagar AV, Key NS, Hogan SL, Hakim RM, Mooney A, Jani CM, Johnson C, Hu Y, Falk RJ, Lazarus JM. Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent dose. J Am Soc Nephrol. 2014;25(4):819-26. Epub 2014/01/25. doi: 10.1681/asn.2013060575. PubMed PMID: 24459231; PMCID: PMC3968502. (Read Abstract)
  14. Caughey MC, Loehr LR, Key NS, Derebail VK, Gottesman RF, Kshirsagar AV, Grove ML, Heiss G. Sickle cell trait and incident ischemic stroke in the Atherosclerosis Risk in Communities study. Stroke. 2014;45(10):2863-7. Epub 2014/08/21. doi: 10.1161/strokeaha.114.006110. PubMed PMID: 25139879; PMCID: PMC4174726. (Read Abstract)
  15. Butler AM, Kshirsagar AV, Brookhart MA. Opioid use in the US hemodialysis population. Am J Kidney Dis. 2014;63(1):171-3. Epub 2013/10/23. doi: 10.1053/j.ajkd.2013.09.008. PubMed PMID: 24145020; PMCID: PMC4086908. (Letter to the Editor)
  16. Brookhart MA, Todd JV, Li X, Reams BD, Pate V, Kshirsagar AV. Estimation of biomarker distributions using laboratory data collected during routine delivery of medical care. Ann Epidemiol. 2014;24(10):754-61. Epub 2014/09/23. doi: 10.1016/j.annepidem.2014.07.013. PubMed PMID: 25238941; PMCID: PMC4476533. (Read Abstract)
  17. Brice JH, Foster MB, Principe S, Moss C, Shofer FS, Falk RJ, Ferris ME, DeWalt DA. Single-item or two-item literacy screener to predict the S-TOFHLA among adult hemodialysis patients. Patient Educ Couns. 2014;94(1):71-5. Epub 2013/10/31. doi: 10.1016/j.pec.2013.09.020. PubMed PMID: 24169024. (Read Abstract)
  18. Berg EA, McGregor JG, Burkart ME, Poulton CJ, Hu Y, Falk RJ, Hogan SL. What Everybody is Doing but No One is Talking About: Use of Complementary and Alternative Medicine in the ANCA Associated Vasculitis Population. J Autoimmune Dis Rheumatol. 2014;2(3):74-91. Epub 2015/01/20. PubMed PMID: 25599078; PMCID: PMC4295716. (Read Abstract)
  19. Bates CM, Charlton JR, Ferris ME, Hildebrandt F, Hoshizaki DK, Warady BA, Moxey-Mims MM. Pediatric kidney disease: tracking onset and improving clinical outcomes. Clin J Am Soc Nephrol. 2014;9(6):1141-3. Epub 2014/03/22. doi: 10.2215/cjn.00860114. PubMed PMID: 24651076; PMCID: PMC4046717. (Read Abstract)

2013 Publications

  1. Xiao H, Ciavatta D, Aylor DL, Hu P, de Villena FP, Falk RJ, Jennette JC. Genetically determined severity of anti-myeloperoxidase glomerulonephritis. Am J Pathol. 2013;182(4):1219-26. Epub 2013/02/07. doi: 10.1016/j.ajpath.2012.12.006. PubMed PMID: 23384999; PMCID: PMC3620395. (Read Abstract)
  2. Wehmeyer MM, Kshirsagar AV, Barros SP, Beck JD, Moss KL, Preisser JS, Offenbacher S. A randomized controlled trial of intensive periodontal therapy on metabolic and inflammatory markers in patients With ESRD: results of an exploratory study. Am J Kidney Dis. 2013;61(3):450-8. Epub 2012/12/25. doi: 10.1053/j.ajkd.2012.10.021. PubMed PMID: 23261122; PMCID: PMC3578050. (Read Abstract)
  3. Roth AJ, Ooi JD, Hess JJ, van Timmeren MM, Berg EA, Poulton CE, McGregor J, Burkart M, Hogan SL, Hu Y, Winnik W, Nachman PH, Stegeman CA, Niles J, Heeringa P, Kitching AR, Holdsworth S, Jennette JC, Preston GA, Falk RJ. Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. J Clin Invest. 2013;123(4):1773-83. Epub 2013/04/04. doi: 10.1172/jci65292. PubMed PMID: 23549081; PMCID: PMC3613913.(Read Abstract)
  4. Poulton CJ, Nachman PH, Hu Y, McGregor JG, Jennette JC, Falk RJ, Hogan SL. Pathways to renal biopsy and diagnosis among patients with ANCA small-vessel vasculitis. Clin Exp Rheumatol. 2013;31(1 Suppl 75):S32-7. Epub 2013/01/25. PubMed PMID: 23343774; PMCID: PMC3800124. (Read Abstract)
  5. Mottl AK, Kwon KS, Mauer M, Mayer-Davis EJ, Hogan SL, Kshirsagar AV. Normoalbuminuric diabetic kidney disease in the U.S. population. J Diabetes Complications. 2013;27(2):123-7. Epub 2012/11/28. doi: 10.1016/j.jdiacomp.2012.09.010. PubMed PMID: 23182925. (Read Abstract)
  6. McGrath LJ, Cole SR, Kshirsagar AV, Weber DJ, Sturmer T, Brookhart MA. Hospitalization and skilled nursing care are predictors of influenza vaccination among patients on hemodialysis: evidence of confounding by frailty. Med Care. 2013;51(12):1106-13. Epub 2013/08/24. doi: 10.1097/MLR.0b013e3182a50297. PubMed PMID: 23969584. (Read Abstract)
  7. Layton JB, Kshirsagar AV, Simpson RJ, Jr., Pate V, Jonsson Funk M, Sturmer T, Brookhart MA. Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. Am J Cardiol. 2013;111(6):823-8. Epub 2013/01/01. doi: 10.1016/j.amjcard.2012.11.047. PubMed PMID: 23273532; PMCID: PMC3637989. (Read Abstract)
  8. Layton JB, Brookhart MA, Jonsson Funk M, Simpson RJ, Jr., Pate V, Sturmer T, Kshirsagar AV. Acute kidney injury in statin initiators. Pharmacoepidemiol Drug Saf. 2013;22(10):1061-70. Epub 2013/08/21. doi: 10.1002/pds.3500. PubMed PMID: 23960024; PMCID: PMC3822439. (Read Abstract)
  9. Kshirsagar AV, Freburger JK, Ellis AR, Wang L, Winkelmayer WC, Brookhart MA. The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med. 2013;126(6):541 e1- e14. Epub 2013/04/20. doi: 10.1016/j.amjmed.2012.11.030. PubMed PMID: 23597800. (Read Abstract)
  10. Kshirsagar AV, Freburger JK, Ellis AR, Wang L, Winkelmayer WC, Brookhart MA. Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients. PLoS One. 2013;8(11):e78930. Epub 2013/11/14. doi: 10.1371/journal.pone.0078930. PubMed PMID: 24223866; PMCID: PMC3815308. (Read Abstract)
  11. Kshirsagar AV, Brookhart MA. The reply. Am J Med. 2013;126(11):e29. Epub 2013/10/26. doi: 10.1016/j.amjmed.2013.07.010. PubMed PMID: 24157299. (Read Text)
  12. Jennette JC, Falk RJ, Hu P, Xiao H. Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu Rev Pathol. 2013;8:139-60. Epub 2013/01/26. doi: 10.1146/annurev-pathol-011811-132453. PubMed PMID: 23347350. (Read Abstract)
  13. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1-11. Epub 2012/10/10. doi: 10.1002/art.37715. PubMed PMID: 23045170. (Read Text)
  14. Hooper DK, Williams JC, Carle AC, Amaral S, Chand DH, Ferris ME, Patel HP, Licht C, Barletta GM, Zitterman V, Mitsnefes M, Patel UD. The quality of cardiovascular disease care for adolescents with kidney disease: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol. 2013;28(6):939-49. Epub 2013/02/19. doi: 10.1007/s00467-013-2419-6. PubMed PMID: 23417277; PMCID: PMC3637925. (Read Abstract)
  15. Gipson DS, Selewski DT, Massengill SF, Wickman L, Messer KL, Herreshoff E, Bowers C, Ferris ME, Mahan JD, Greenbaum LA, MacHardy J, Kapur G, Chand DH, Goebel J, Barletta GM, Geary D, Kershaw DB, Pan CG, Gbadegesin R, Hidalgo G, Lane JC, Leiser JD, Plattner BW, Song PX, Thissen D, Liu Y, Gross HE, DeWalt DA. Gaining the PROMIS perspective from children with nephrotic syndrome: a Midwest pediatric nephrology consortium study. Health Qual Life Outcomes. 2013;11:30. Epub 2013/03/21. doi: 10.1186/1477-7525-11-30. PubMed PMID: 23510630; PMCID: PMC3599189. (Read Abstract)
  16. Free ME, Ciavatta DJ, Falk RJ. L26. How antigens influence the disease: an immunologist point of view. Presse Med. 2013;42(4 Pt 2):577-9. Epub 2013/03/05. doi: 10.1016/j.lpm.2013.01.026. PubMed PMID: 23454000. 
  17. Free ME, Bunch DO, McGregor JA, Jones BE, Berg EA, Hogan SL, Hu Y, Preston GA, Jennette JC, Falk RJ, Su MA. Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population. Arthritis Rheum. 2013;65(7):1922-33. Epub 2013/04/05. doi: 10.1002/art.37959. PubMed PMID: 23553415; PMCID: PMC3717615. (Read Abstract)
  18. Falk RJ. ASN presidential address 2012: Time to cure kidney disease. J Am Soc Nephrol. 2013;24(7):1040-3. Epub 2013/06/08. doi: 10.1681/asn.2013050440. PubMed PMID: 23744889. (Read Text)
  19. Dellon ES, Jones PD, Martin NB, Kelly M, Kim SC, Freeman KL, Dellon EP, Ferris ME, Shaheen NJ. Health-care transition from pediatric to adult-focused gastroenterology in patients with eosinophilic esophagitis. Dis Esophagus. 2013;26(1):7-13. Epub 2012/02/09. doi: 10.1111/j.1442-2050.2011.01315.x. PubMed PMID: 22309247; PMCID: PMC3349775. (Read Text)
  20. Costa NA, Kshirsagar AV, Wang L, Detwiler RK, Brookhart MA. Pretransplantation erythropoiesis-stimulating agent hyporesponsiveness is associated with increased kidney allograft failure and mortality. Transplantation. 2013;96(9):807-13. Epub 2013/08/29. doi: 10.1097/TP.0b013e3182a0f668. PubMed PMID: 23982339; PMCID: PMC4089212. (Read Abstract)
  21. Charles Jennette J, Falk RJ. L1. Pathogenesis of ANCA-associated vasculitis: observations, theories and speculations. Presse Med. 2013;42(4 Pt 2):493-8. Epub 2013/03/08. doi: 10.1016/j.lpm.2013.01.003. PubMed PMID: 23465301. (Read Text)
  22. Bunch DO, McGregor JG, Khandoobhai NB, Aybar LT, Burkart ME, Hu Y, Hogan SL, Poulton CJ, Berg EA, Falk RJ, Nachman PH. Decreased CD5(+) B cells in active ANCA vasculitis and relapse after rituximab. Clin J Am Soc Nephrol. 2013;8(3):382-91. Epub 2013/01/08. doi: 10.2215/cjn.03950412. PubMed PMID: 23293123; PMCID: PMC3586963. (Read Abstract)
  23. Brookhart MA, Freburger JK, Ellis AR, Wang L, Winkelmayer WC, Kshirsagar AV. Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients. J Am Soc Nephrol. 2013;24(7):1151-8. Epub 2013/06/22. doi: 10.1681/asn.2012121164. PubMed PMID: 23787911; PMCID: PMC3699831. (Read Abstract)
  24. Beaubrun AC, Brookhart MA, Sleath B, Wang L, Kshirsagar AV. Trends and variations in intravenous vitamin D use among hemodialysis patients in the United States. Ren Fail. 2013;35(1):1-8. Epub 2012/10/24. doi: 10.3109/0886022x.2012.734260. PubMed PMID: 23088380. (Read Abstract)
  25. Archdeacon P, Shaffer RN, Winkelmayer WC, Falk RJ, Roy-Chaudhury P. Fostering innovation, advancing patient safety: the kidney health initiative. Clin J Am Soc Nephrol. 2013;8(9):1609-17. Epub 2013/06/08. doi: 10.2215/cjn.01140113. PubMed PMID: 23744001; PMCID: PMC3805066. (Read Abstract) 

2012 Publications

  1. Roth AJBrown MC, Smith RN, Badhwar AK, Parente O, Chung H, Bunch DOMcGregor JGHogan SLHu YYang JJBerg EA, Niles J, Jennette JC, Preston GAFalk RJAnti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis. J Am Soc Nephrol. 2012;23(3):545-55. Epub 2011/10/25. doi: 10.1681/asn.2011030273. PubMed PMID: 22021709; PMCID: PMC3294309. (Read Abstract)
  2. Mottl AK, Kwon KS, Garg S, Mayer-Davis EJ, Klein R, Kshirsagar AV. The association of retinopathy and low GFR in type 2 diabetes. Diabetes Res Clin Pract. 2012;98(3):487-93. Epub 2012/10/17. doi: 10.1016/j.diabres.2012.09.041. PubMed PMID: 23068959. (Read Abstract)
  3. McGregor JG, Hogan SL, Hu Y, Jennette CE, Falk RJ, Nachman PH. Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease. Clin J Am Soc Nephrol. 2012;7(2):240-7. Epub 2011/12/03. doi: 10.2215/cjn.05610611. PubMed PMID: 22134625; PMCID: PMC3280023. (Read Abstract)
  4. McGregor JG, Falk RJ. Vasculitis: the elusive optimal induction strategy for vasculitis. Nat Rev Nephrol. 2012;8(4):195-6. Epub 2012/02/09. doi: 10.1038/nrneph.2012.16. PubMed PMID: 22310953. (Read Text)
  5. McGrath LJ, Kshirsagar AV, Cole SR, Wang L, Weber DJ, Sturmer T, Brookhart MA. Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment. Arch Intern Med. 2012;172(7):548-54. Epub 2012/04/12. doi: 10.1001/archinternmed.2011.2238. PubMed PMID: 22493462; PMCID: PMC4082376. (Read Abstract)
  6. McGrath LJ, Kshirsagar AV. Influenza and pneumococcal vaccination in dialysis patients: merely a shot in the arm? Am J Kidney Dis. 2012;60(6):890-2. Epub 2012/11/13. doi: 10.1053/j.ajkd.2012.09.001. PubMed PMID: 23141997. (Read Text)
  7. Lionaki S, Derebail VK, Hogan SL, Barbour S, Lee T, Hladunewich M, Greenwald A, Hu Y, Jennette CE, Jennette JC, Falk RJ, Cattran DC, Nachman PH, Reich HN. Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol. 2012;7(1):43-51. Epub 2011/11/15. doi: 10.2215/cjn.04250511. PubMed PMID: 22076873; PMCID: PMC3265338. (Read Abstract)
  8. Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior BA, Jennette CE, Nachman PH, Jennette JC, Falk RJ. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum. 2012;64(10):3452-62. Epub 2012/10/02. doi: 10.1002/art.34562. PubMed PMID: 23023777; PMCID: PMC3462364. (Read Abstract)
  9. Kwon KS, Bang H, Bomback AS, Koh DH, Yum JH, Lee JH, Lee S, Park SK, Yoo KY, Park SK, Chang SH, Lim HS, Choi JM, Kshirsagar AV. A simple prediction score for kidney disease in the Korean population. Nephrology (Carlton). 2012;17(3):278-84. Epub 2011/12/17. doi: 10.1111/j.1440-1797.2011.01552.x. PubMed PMID: 22171932. (Read Abstract)
  10. Joy MS, La M, Wang J, Bridges AS, Hu Y, Hogan SL, Frye RF, Blaisdell J, Goldstein JA, Dooley MA, Brouwer KL, Falk RJ. Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis. Br J Clin Pharmacol. 2012;74(3):445-55. Epub 2012/03/03. doi: 10.1111/j.1365-2125.2012.04223.x. PubMed PMID: 22380717; PMCID: PMC3477346. (Read Abstract)
  11. Garg S, Jani PD, Kshirsagar AV, King B, Chaum E. Telemedicine and retinal imaging for improving diabetic retinopathy evaluation. Arch Intern Med. 2012;172(21):1677-8. Epub 2012/10/03. doi: 10.1001/archinternmed.2012.4372. PubMed PMID: 23026969. (Read Text)
  12. Freburger JK, Ng LJ, Bradbury BD, Kshirsagar AV, Brookhart MA. Changing patterns of anemia management in US hemodialysis patients. Am J Med. 2012;125(9):906-14 e9. Epub 2012/09/04. doi: 10.1016/j.amjmed.2012.03.011. PubMed PMID: 22938926. (Read Abstract)
  13. Ferris ME, Harward DH, Bickford K, Layton JB, Ferris MT, Hogan SL, Gipson DS, McCoy LP, Hooper SR. A clinical tool to measure the components of health-care transition from pediatric care to adult care: the UNC TR(x)ANSITION scale. Ren Fail. 2012;34(6):744-53. Epub 2012/05/16. doi: 10.3109/0886022x.2012.678171. PubMed PMID: 22583152. (Read Abstract)
  14. Cao Y, Yang J, Colby K, Hogan SL, Hu Y, Jennette CE, Berg EA, Zhang Y, Jennette JC, Falk RJ, Preston GA. High basal activity of the PTPN22 gain-of-function variant blunts leukocyte responsiveness negatively affecting IL-10 production in ANCA vasculitis. PLoS One. 2012;7(8):e42783. Epub 2012/08/11. doi: 10.1371/journal.pone.0042783. PubMed PMID: 22880107; PMCID: PMC3411839. (Read Abstract)